13D/13G Filings - Versant Venture Capital VI, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-11
5:58 pm
Unchanged
2024-11-12 13D Tempest Therapeutics, Inc.
TPST
Versant Venture Capital VI, L.P. 2,118,644
4.800%
0
(Unchanged)
Filing
History
2024-11-08
5:08 pm
Unchanged
2024-08-14 13D LENZ Therapeutics, Inc.
LENZ
Versant Venture Capital VI, L.P. 2,101,199
7.600%
0
(Unchanged)
Filing
History
2024-10-30
5:10 pm
Sale
2024-10-28 13D Monte Rosa Therapeutics, Inc.
GLUE
Versant Venture Capital VI, L.P. 4,079,469
6.600%
-1,019,867decrease
(-20.00%)
Filing
History
2024-09-24
5:00 pm
Sale
2024-09-20 13D Monte Rosa Therapeutics, Inc.
GLUE
Versant Venture Capital VI, L.P. 5,099,336
8.300%
-1,699,779decrease
(-25.00%)
Filing
History
2024-08-12
8:59 pm
Unchanged
2024-08-08 13D Tempest Therapeutics, Inc.
TPST
Versant Venture Capital VI, L.P. 2,118,644
8.400%
0
(Unchanged)
Filing
History
2024-08-12
5:07 pm
Unchanged
2024-08-08 13D Monte Rosa Therapeutics, Inc.
GLUE
Versant Venture Capital VI, L.P. 6,799,115
11.100%
0
(Unchanged)
Filing
History
2024-08-09
7:06 pm
Sale
2024-08-07 13D Passage Bio, Inc.
PASG
Versant Venture Capital VI, L.P. 0
0.000%
-4,026,417decrease
(Position Closed)
Filing
History
2024-08-08
4:48 pm
Unchanged
2024-08-06 13D Black Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI, L.P. 4,328,883
7.700%
0
(Unchanged)
Filing
History
2024-05-29
4:35 pm
Unchanged
2024-05-24 13D Passage Bio, Inc.
PASG
Versant Venture Capital VI, L.P. 4,026,417
6.500%
0
(Unchanged)
Filing
History
2024-05-13
4:54 pm
Unchanged
2024-03-19 13D Tempest Therapeutics, Inc.
TPST
Versant Venture Capital VI, L.P. 2,118,644
9.500%
0
(Unchanged)
Filing
History
2024-03-25
4:43 pm
Purchase
2024-03-21 13D LENZ Therapeutics, Inc.
LENZ
Versant Venture Capital VI, L.P. 2,101,199
8.200%
2,101,199increase
(New Position)
Filing
History
2024-02-08
5:44 pm
Unchanged
2023-11-02 13D Aligos Therapeutics, Inc.
ALGS
Versant Venture Capital VI, L.P. 58,317
1.900%
0
(Unchanged)
Filing
History
2024-02-08
5:41 pm
Unchanged
2023-11-08 13D Tempest Therapeutics, Inc.
TPST
Versant Venture Capital VI, L.P. 2,118,644
11.000%
0
(Unchanged)
Filing
History
2024-02-08
5:35 pm
Unchanged
2023-12-31 13G Century Therapeutics, Inc.
IPSC
Versant Venture Capital VI, L.P. 11,452,014
19.100%
0
(Unchanged)
Filing
History
2023-11-17
4:38 pm
Unchanged
2023-11-14 13D Graphite Bio, Inc.
GRPH
Versant Venture Capital VI, L.P. 2,101,200
25.400%
0
(Unchanged)
Filing
History
2023-11-09
5:28 pm
Unchanged
2023-08-10 13D Tempest Therapeutics, Inc.
TPST
Versant Venture Capital VI, L.P. 2,118,644
15.900%
0
(Unchanged)
Filing
History
2023-11-09
5:27 pm
Unchanged
2023-08-07 13D Passage Bio, Inc.
PASG
Versant Venture Capital VI, L.P. 4,026,417
7.300%
0
(Unchanged)
Filing
History
2023-11-09
5:26 pm
Unchanged
2023-08-10 13D Monte Rosa Therapeutics, Inc.
GLUE
Versant Venture Capital VI, L.P. 6,799,115
13.700%
0
(Unchanged)
Filing
History
2023-11-09
5:24 pm
Unchanged
2023-08-11 13D Black Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI, L.P. 4,328,883
8.400%
0
(Unchanged)
Filing
History
2023-02-09
4:19 pm
Sale
2022-12-31 13G Century Therapeutics, Inc.
IPSC
Versant Venture Capital VI, L.P. 11,452,014
19.400%
-914,800decrease
(-7.40%)
Filing
History
Goto 0, 1, 2, Next